Danone’s share prices have dropped following its recall of batches of infant formula in Europe and Asia last week.
The French consumer goods group recalled a specific batches of baby formula in Singapore and Europe over fears they contained the toxin cereulide.
In the UK, the recall only impacts 800g packs of the formula a best before date of 31 October 2026, which were sold between May and July 2025.
Cereulide is a toxin produced by some strains of Bacillus cereus. It is highly heat-stable, meaning it is unlikely to be deactivated or destroyed by cooking, using boiling water or when making the infant milk.
The Food Safety Authority of Ireland said the recall was connected to the same ingredient, an arachidonic acid oil (ARA oil) manufactured in China, that had triggered Nestlé’s recall of a swathe of SMA infant and follow-on formula products earlier this month.
As reported by the FT, Danone’s share price dropped as much as 5.9% today (26 January) before clawing back some losses to trade down 2.5%. The stock fell by about 10% last week.
The FSA has urged shoppers not to feed the impacted product to babies. Even if they have used the product and not identified ill-health in their baby, they should stop using it.
If they have fed it to a baby and have any concerns about its potential health impact, they should seek the advice of a healthcare professional. Meanwhile, they should also consult a pharmacist or other medical professional before changing formula if the product was prescribed to their baby.
Danone has issued point of sale notices to all retail stores selling the product.
It has urged shoppers who have a product from the affected batch to return it to the shop where they bought it for a full refund with or without a receipt.
If they have any questions, they can contact the Aptamil Careline team on 0800 996 1000 or via its website at aptaclub.co.uk.
No comments yet